tetano
Editor, Senior Moderator
Virus Res
. 2021 Nov 14;198631.
doi: 10.1016/j.virusres.2021.198631. Online ahead of print.
The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review
Sujay Paul[SUP] 1 [/SUP], Luis Alberto Bravo Vázquez[SUP] 2 [/SUP], Paula Roxana Reyes-Pérez[SUP] 2 [/SUP], Carolina Estrada-Meza[SUP] 2 [/SUP], Rafael Arturo Aponte Alburquerque[SUP] 2 [/SUP], Surajit Pathak[SUP] 3 [/SUP], Antara Banerjee[SUP] 3 [/SUP], Anindya Bandyopadhyay[SUP] 4 [/SUP], Samik Chakraborty[SUP] 5 [/SUP], Aashish Srivastava[SUP] 6 [/SUP]
Affiliations
Abstract
Nowadays, one of the major global health concerns is coronavirus disease 2019 (COVID-19), which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Even though numerous treatments and vaccines to combat this virus are currently under development, the detailed molecular mechanisms underlying the pathogenesis of this disease are yet to be elucidated to design future therapeutic tools against SARS-CoV-2 variants. MicroRNAs (miRNAs) are small (20-24 nucleotides), non-coding RNA molecules that regulate post-transcriptional gene expression. Recently, it has been demonstrated that both host and viral-encoded miRNAs are crucial for the successful infection of SARS-CoV-2. For instance, dysregulation of miRNAs that modulate multiple genes expressed in COVID-19 patients with comorbidities (e.g., type 2 diabetes, lung adenocarcinoma, and cerebrovascular disorders) could affect the severity of the disease. Thus, altered expression levels of circulating miRNAs might be helpful to diagnose this illness and forecast whether a COVID-19 patient could develop a severe state of the disease. Besides, researchers have found a number of miRNAs could inhibit the expression of proteins such as ACE2, TMPRSS2, spike, and Nsp12, involved in the life cycle of SARS-CoV-2. Accordingly, miRNAs represent potential biomarkers and therapeutic targets for this devastating viral disease. Therefore, in this current review, we present the recent discoveries regarding the clinical relevance and biological roles of miRNAs in COVID-19.
Keywords: COVID-19; MicroRNAs; SARS-CoV-2; biomarker; gene regulation; miRNA-based therapeutics.
. 2021 Nov 14;198631.
doi: 10.1016/j.virusres.2021.198631. Online ahead of print.
The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review
Sujay Paul[SUP] 1 [/SUP], Luis Alberto Bravo Vázquez[SUP] 2 [/SUP], Paula Roxana Reyes-Pérez[SUP] 2 [/SUP], Carolina Estrada-Meza[SUP] 2 [/SUP], Rafael Arturo Aponte Alburquerque[SUP] 2 [/SUP], Surajit Pathak[SUP] 3 [/SUP], Antara Banerjee[SUP] 3 [/SUP], Anindya Bandyopadhyay[SUP] 4 [/SUP], Samik Chakraborty[SUP] 5 [/SUP], Aashish Srivastava[SUP] 6 [/SUP]
Affiliations
- PMID: 34788642
- DOI: 10.1016/j.virusres.2021.198631
Abstract
Nowadays, one of the major global health concerns is coronavirus disease 2019 (COVID-19), which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Even though numerous treatments and vaccines to combat this virus are currently under development, the detailed molecular mechanisms underlying the pathogenesis of this disease are yet to be elucidated to design future therapeutic tools against SARS-CoV-2 variants. MicroRNAs (miRNAs) are small (20-24 nucleotides), non-coding RNA molecules that regulate post-transcriptional gene expression. Recently, it has been demonstrated that both host and viral-encoded miRNAs are crucial for the successful infection of SARS-CoV-2. For instance, dysregulation of miRNAs that modulate multiple genes expressed in COVID-19 patients with comorbidities (e.g., type 2 diabetes, lung adenocarcinoma, and cerebrovascular disorders) could affect the severity of the disease. Thus, altered expression levels of circulating miRNAs might be helpful to diagnose this illness and forecast whether a COVID-19 patient could develop a severe state of the disease. Besides, researchers have found a number of miRNAs could inhibit the expression of proteins such as ACE2, TMPRSS2, spike, and Nsp12, involved in the life cycle of SARS-CoV-2. Accordingly, miRNAs represent potential biomarkers and therapeutic targets for this devastating viral disease. Therefore, in this current review, we present the recent discoveries regarding the clinical relevance and biological roles of miRNAs in COVID-19.
Keywords: COVID-19; MicroRNAs; SARS-CoV-2; biomarker; gene regulation; miRNA-based therapeutics.